allogeneic cardiosphere-derived cells
Cell therapyexperimental
Clinical trial activity
10 trials · 9 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
7
Phase 3
1
Phase 4
0
Earliest trial started Oct 1, 2012 (NCT01458405)
Timeline
Indications
Studied for
- Cardiomyopathies · Phase 1/Phase 2
- COVID-19 · Phase 2
- Genetic Diseases, Inborn · Phase 3
- Genetic Diseases, X-Linked · Phase 3
- Heart Failure · Phase 1
- Muscular Diseases · Phase 3
- Muscular Disorders, Atrophic · Phase 3
- Muscular Dystrophies · Phase 3
- Muscular Dystrophy, Duchenne · Phase 3
- Myocardial Infarction · Phase 1/Phase 2
- Myocardial Ischemia · Phase 1
- Nervous System Diseases · Phase 3
- Neuromuscular Diseases · Phase 3
Mechanism of action
- Cardiac muscle cellTissue restoration
Cardiac muscle cell tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- allogeneic cardiosphere-derived cells
- cap-1002
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05126758 | Phase 3 | Jan 1, 2022 | Capricor Inc., University of California, Davis |
| NCT04623671 | Phase 2 | Nov 15, 2020 | Capricor Inc. |
| NCT04428476 | Phase 2 | Jul 31, 2020 | Capricor Inc., University of California, Davis |
| NCT04696328 | Phase 1 | Dec 2, 2019 | Cuorips Inc., Osaka University |
| NCT06304064 | Phase 2 | Jun 21, 2018 | Capricor Inc. |
| NCT03406780 | Phase 2 | Apr 4, 2018 | Capricor Inc., University of California, Davis |
| NCT02485938 | Phase 1/Phase 2 (Phase 2) | Aug 1, 2015 | Capricor Inc., University of Cincinnati |
| NCT02293603 | Phase 1 | Nov 1, 2014 | Capricor Inc., Cedars-Sinai Medical Center, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH) |
| NCT01458405 | Phase 1/Phase 2 (Phase 2) | Oct 1, 2012 | California Institute for Regenerative Medicine, Capricor Inc., National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH) |
| NCT04338347 | N/A | — | Capricor Inc., Cedars-Sinai Medical Center |
Showing 10 of 10 trials
Page 1 / 1
Organizations
Research & Development (9)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Capricor Inc. | For profit | 9 | 9 | 4 | 2012 |
| University of California, Davis | Academic/Hospital | 3 | 0 | 2 | 2018 |
| Cedars-Sinai Medical Center | Academic/Hospital | 2 | 0 | 2 | 2014 |
| National Heart, Lung, and Blood Institute (NHLBI) | Government | 2 | 0 | 2 | 2012 |
| National Institutes of Health (NIH) | Government | 2 | 0 | 2 | 2012 |
| California Institute for Regenerative Medicine | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Cuorips Inc. | For profit | 1 | 0 | 1 | 2019 |
| Osaka University | Academic/Hospital | 1 | 1 | 1 | 2019 |
| University of Cincinnati | Academic/Hospital | 1 | 0 | 1 | 2015 |
9 organizations
Page 1 / 1